Naftalofos

This classification denotes an antihelminthic agent with the molecular formula C16H16NO6P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H5IT2P8H5I, chemically known as 1h-benz(de)isoquinoline-1,3(2h)-dione, 2-((diethoxyphosphinyl)oxy)- but generally known as naftalofos, which bears US NIH Compound Identifier 15148. European Medicines Agency schedules Naftalofos in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09128MIG. The term NAFTALOFOS is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). NAFTALOFOS is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule naftalofos under HS 29299000 and SITC 51489. As of Q4 2014, NAFTALOFOS remains the US FDA Preferred Term for this commodity. Naftalofos bears US NLM identifiers UMLS ID C0068365 and NCI Concept Code C90727. SMILES: P(=O)(ON1C(=O)C2C3C(C1=O)CCCC3CCC2)(OCC)OCC.